Suppr超能文献

机器人辅助食管癌切除术联合胸导管切除术的短期临床效果

Short-term clinical effects of robot-assisted esophagectomy with thoracic duct resection.

作者信息

Li Chunguang, Li Bin, Yang Yang, Li Zhigang

机构信息

Department of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

J Gastrointest Oncol. 2023 Feb 28;14(1):11-21. doi: 10.21037/jgo-22-985. Epub 2023 Feb 21.

Abstract

BACKGROUND

Whether extended robot-assisted esophagectomy with thoracic duct resection (RAE-TDR) has a favorable effect on esophageal cancer patients is not yet known. This study sought to analyze the safety and efficiency of RAE-TDR.

METHODS

From January 2019 to July 2020, 73 thoracic duct (TD)-resected and 127 TD-preserved consecutive patients who received standard RAE McKeown surgery were enrolled in this study. The perioperative-related indicators of recurrence-free survival (RFS) and overall survival (OS) at 1-year were compared between the 2 groups.

RESULTS

In relation to morbidity, the Clavien-Dindo (CD) classifications for grades greater than or equal to II-III were similar between the 2 groups (P>0.05). The number of retrieved total lymph nodes (LNs) and mediastinal nodes were significantly higher in the TD-resected group than in the TD-preserved group (total lymph nodes: 29.0±11.1 25.1±8.5, P=0.006; mediastinal nodes: 19.5±8.0 16.1±5.5, P=0.002). Additionally, more metastatic TD-related LNs were harvested in cT3-4 patients (2.3±3.7 1.7±2.8; P=0.21). The rates of LN recurrence and local recurrence were similar between the 2 groups (LN recurrence: 6.8% 7.1%, P>0.99; local recurrence: 1.4% 2.4%, P>0.99). The OS and RFS at 1-year were equivalent regardless of the TD procedure at each stage (P>0.05). However, the rate of hematogenous metastasis in the TD-resected group was significantly elevated (17.8% 7.9%; P=0.034).

CONCLUSIONS

RAE-TDR may help to improve total and metastatic LN harvest, especially in patients with advanced esophageal squamous cell carcinoma (ESCC) without increasing the intra- and post-operative adverse events. However, RAE-TDR did not lead to a decrease in the local recurrence rate within the short-term follow-up period. Whether the increase in distant metastasis rate in the TD-resected group was associated with relevant immune system damage is unclear. Thus, nonselective RAE-TDR is not routinely recommended.

摘要

背景

扩大的机器人辅助食管癌切除术联合胸导管切除术(RAE-TDR)对食管癌患者是否具有良好效果尚不清楚。本研究旨在分析RAE-TDR的安全性和有效性。

方法

2019年1月至2020年7月,本研究纳入了73例行胸导管(TD)切除术和127例行TD保留术且接受标准RAE McKeown手术的连续患者。比较两组患者1年无复发生存期(RFS)和总生存期(OS)的围手术期相关指标。

结果

在发病率方面,两组中Clavien-Dindo(CD)分级大于或等于II-III级的情况相似(P>0.05)。TD切除组回收的总淋巴结(LN)和纵隔淋巴结数量显著高于TD保留组(总淋巴结:29.0±11.1对25.1±8.5,P=0.006;纵隔淋巴结:19.5±8.0对16.1±5.5,P=0.002)。此外,cT3-4患者中收获的与TD相关的转移LN更多(2.3±3.7对1.7±2.8;P=0.21)。两组的LN复发率和局部复发率相似(LN复发:6.8%对7.1%,P>0.99;局部复发:1.4%对2.4%,P>0.99)。无论各阶段的TD手术如何,1年时的OS和RFS相当(P>0.05)。然而,TD切除组的血行转移率显著升高(17.8%对7.9%;P=0.034)。

结论

RAE-TDR可能有助于提高总LN和转移LN的收获量,尤其是在晚期食管鳞状细胞癌(ESCC)患者中,且不增加术中和术后不良事件。然而,在短期随访期内,RAE-TDR并未导致局部复发率降低。TD切除组远处转移率的增加是否与相关免疫系统损伤有关尚不清楚。因此,不常规推荐非选择性RAE-TDR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721f/10007922/ca524ba8412c/jgo-14-01-11-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验